Skip to main content
PMC home page
Molecular Pathology : MP logoLink to Molecular Pathology : MP
. 1997 Apr;50(2):72–76. doi: 10.1136/mp.50.2.72

Pathogenic mechanisms of neuronal damage in the AIDS dementia complex.

S Swingler 1
PMCID: PMC379586  PMID: 9231153

Full text

PDF
72

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aylward E. H., Henderer J. D., McArthur J. C., Brettschneider P. D., Harris G. J., Barta P. E., Pearlson G. D. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology. 1993 Oct;43(10):2099–2104. doi: 10.1212/wnl.43.10.2099. [DOI] [PubMed] [Google Scholar]
  2. Benos D. J., Hahn B. H., Bubien J. K., Ghosh S. K., Mashburn N. A., Chaikin M. A., Shaw G. M., Benveniste E. N. Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):494–498. doi: 10.1073/pnas.91.2.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Benos D. J., McPherson S., Hahn B. H., Chaikin M. A., Benveniste E. N. Cytokines and HIV envelope glycoprotein gp120 stimulate Na+/H+ exchange in astrocytes. J Biol Chem. 1994 May 13;269(19):13811–13816. [PubMed] [Google Scholar]
  4. Bito H., Nakamura M., Honda Z., Izumi T., Iwatsubo T., Seyama Y., Ogura A., Kudo Y., Shimizu T. Platelet-activating factor (PAF) receptor in rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neurons. Neuron. 1992 Aug;9(2):285–294. doi: 10.1016/0896-6273(92)90167-c. [DOI] [PubMed] [Google Scholar]
  5. Brenneman D. E., McCune S. K., Mervis R. F., Hill J. M. gp120 as an etiologic agent for NeuroAIDS: neurotoxicity and model systems. Adv Neuroimmunol. 1994;4(3):157–165. doi: 10.1016/s0960-5428(06)80252-4. [DOI] [PubMed] [Google Scholar]
  6. Brenneman D. E., Westbrook G. L., Fitzgerald S. P., Ennist D. L., Elkins K. L., Ruff M. R., Pert C. B. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 1988 Oct 13;335(6191):639–642. doi: 10.1038/335639a0. [DOI] [PubMed] [Google Scholar]
  7. Brew B. J., Rosenblum M., Cronin K., Price R. W. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol. 1995 Oct;38(4):563–570. doi: 10.1002/ana.410380404. [DOI] [PubMed] [Google Scholar]
  8. Brew B. J., Rosenblum M., Price R. W. AIDS dementia complex and primary HIV brain infection. J Neuroimmunol. 1988 Dec;20(2-3):133–140. doi: 10.1016/0165-5728(88)90144-0. [DOI] [PubMed] [Google Scholar]
  9. Brew B. J. The clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathy. Curr Opin Neurol. 1994 Jun;7(3):209–216. doi: 10.1097/00019052-199406000-00006. [DOI] [PubMed] [Google Scholar]
  10. Budka H. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis. Acta Neuropathol. 1989;77(3):225–236. doi: 10.1007/BF00687573. [DOI] [PubMed] [Google Scholar]
  11. Dawson T. M., Dawson V. L. gp120 neurotoxicity in primary cortical cultures. Adv Neuroimmunol. 1994;4(3):167–173. doi: 10.1016/s0960-5428(06)80253-6. [DOI] [PubMed] [Google Scholar]
  12. Everall I. P., Hudson L., al-Sarraj S., Honavar M., Lantos P., Kerwin R. Decreased expression of AMPA receptor messenger RNA and protein in AIDS: a model for HIV-associated neurotoxicity. Nat Med. 1995 Nov;1(11):1174–1178. doi: 10.1038/nm1195-1174. [DOI] [PubMed] [Google Scholar]
  13. Fine S. M., Angel R. A., Perry S. W., Epstein L. G., Rothstein J. D., Dewhurst S., Gelbard H. A. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J Biol Chem. 1996 Jun 28;271(26):15303–15306. doi: 10.1074/jbc.271.26.15303. [DOI] [PubMed] [Google Scholar]
  14. Gallo P., De Rossi A., Amadori A., Tavolato B., Chieco-Bianchi L. Central nervous system involvement in HIV infection. AIDS Res Hum Retroviruses. 1988 Jun;4(3):211–221. doi: 10.1089/aid.1988.4.211. [DOI] [PubMed] [Google Scholar]
  15. Gelbard H. A., Dzenko K. A., DiLoreto D., del Cerro C., del Cerro M., Epstein L. G. Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev Neurosci. 1993;15(6):417–422. doi: 10.1159/000111367. [DOI] [PubMed] [Google Scholar]
  16. Gelbard H. A., Nottet H. S., Swindells S., Jett M., Dzenko K. A., Genis P., White R., Wang L., Choi Y. B., Zhang D. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol. 1994 Jul;68(7):4628–4635. doi: 10.1128/jvi.68.7.4628-4635.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Genis P., Jett M., Bernton E. W., Boyle T., Gelbard H. A., Dzenko K., Keane R. W., Resnick L., Mizrachi Y., Volsky D. J. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med. 1992 Dec 1;176(6):1703–1718. doi: 10.1084/jem.176.6.1703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Giulian D., Lachman L. B. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science. 1985 Apr 26;228(4698):497–499. doi: 10.1126/science.3872478. [DOI] [PubMed] [Google Scholar]
  19. Gray F., Bélec L., Keohane C., De Truchis P., Clair B., Durigon M., Sobel A., Gherardi R. Zidovudine therapy and HIV encephalitis: a 10-year neuropathological survey. AIDS. 1994 Apr;8(4):489–493. doi: 10.1097/00002030-199404000-00011. [DOI] [PubMed] [Google Scholar]
  20. Griffin D. E., Wesselingh S. L., McArthur J. C. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol. 1994 May;35(5):592–597. doi: 10.1002/ana.410350513. [DOI] [PubMed] [Google Scholar]
  21. Hogan M. M., Vogel S. N. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins. J Immunol. 1988 Dec 15;141(12):4196–4202. [PubMed] [Google Scholar]
  22. Ketzler S., Weis S., Haug H., Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol. 1990;80(1):92–94. doi: 10.1007/BF00294228. [DOI] [PubMed] [Google Scholar]
  23. Koenig S., Gendelman H. E., Orenstein J. M., Dal Canto M. C., Pezeshkpour G. H., Yungbluth M., Janotta F., Aksamit A., Martin M. A., Fauci A. S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 1986 Sep 5;233(4768):1089–1093. doi: 10.1126/science.3016903. [DOI] [PubMed] [Google Scholar]
  24. Kuiken C. L., Goudsmit J., Weiller G. F., Armstrong J. S., Hartman S., Portegies P., Dekker J., Cornelissen M. Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex. J Gen Virol. 1995 Jan;76(Pt 1):175–180. doi: 10.1099/0022-1317-76-1-175. [DOI] [PubMed] [Google Scholar]
  25. Levin H. S., Williams D. H., Borucki M. J., Hillman G. R., Williams J. B., Guinto F. C., Jr, Amparo E. G., Crow W. N., Pollard R. B. Magnetic resonance imaging and neuropsychological findings in human immunodeficiency virus infection. J Acquir Immune Defic Syndr. 1990;3(8):757–762. [PubMed] [Google Scholar]
  26. Lipton S. A. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists. Dev Neurosci. 1994;16(3-4):145–151. doi: 10.1159/000112101. [DOI] [PubMed] [Google Scholar]
  27. Lipton S. A., Yeh M., Dreyer E. B. Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide. Adv Neuroimmunol. 1994;4(3):181–188. doi: 10.1016/s0960-5428(06)80255-x. [DOI] [PubMed] [Google Scholar]
  28. Magnuson D. S., Knudsen B. E., Geiger J. D., Brownstone R. M., Nath A. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol. 1995 Mar;37(3):373–380. doi: 10.1002/ana.410370314. [DOI] [PubMed] [Google Scholar]
  29. Masliah E., Ge N., Achim C. L., Hansen L. A., Wiley C. A. Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol. 1992 Nov;51(6):585–593. doi: 10.1097/00005072-199211000-00003. [DOI] [PubMed] [Google Scholar]
  30. Matthews S., Barlow P., Boyd J., Barton G., Russell R., Mills H., Cunningham M., Meyers N., Burns N., Clark N. Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma. Nature. 1994 Aug 25;370(6491):666–668. doi: 10.1038/370666a0. [DOI] [PubMed] [Google Scholar]
  31. Meyenhofer M. F., Epstein L. G., Cho E. S., Sharer L. R. Ultrastructural morphology and intracellular production of human immunodeficiency virus (HIV) in brain. J Neuropathol Exp Neurol. 1987 Jul;46(4):474–484. doi: 10.1097/00005072-198707000-00006. [DOI] [PubMed] [Google Scholar]
  32. Moses A. V., Nelson J. A. HIV infection of human brain capillary endothelial cells--implications for AIDS dementia. Adv Neuroimmunol. 1994;4(3):239–247. doi: 10.1016/s0960-5428(06)80262-7. [DOI] [PubMed] [Google Scholar]
  33. Möller A. A., Gasser T., Jäger H., Hedl A. Clinical course of subacute HIV encephalitis. J Neuroimmunol. 1988 Dec;20(2-3):145–147. doi: 10.1016/0165-5728(88)90146-4. [DOI] [PubMed] [Google Scholar]
  34. Navia B. A., Price R. W. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol. 1987 Jan;44(1):65–69. doi: 10.1001/archneur.1987.00520130051017. [DOI] [PubMed] [Google Scholar]
  35. Neuen-Jacob E., Arendt G., Wendtland B., Jacob B., Schneeweis M., Wechsler W. Frequency and topographical distribution of CD68-positive macrophages and HIV-1 core proteins in HIV-associated brain lesions. Clin Neuropathol. 1993 Nov-Dec;12(6):315–324. [PubMed] [Google Scholar]
  36. Nottet H. S., Gendelman H. E. Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol Today. 1995 Sep;16(9):441–448. doi: 10.1016/0167-5699(95)80022-0. [DOI] [PubMed] [Google Scholar]
  37. Parravicini C. L., Klatzmann D., Jaffray P., Costanzi G., Gluckman J. C. Monoclonal antibodies to the human immunodeficiency virus p18 protein cross-react with normal human tissues. AIDS. 1988 Jun;2(3):171–177. [PubMed] [Google Scholar]
  38. Petito C. K., Cho E. S., Lemann W., Navia B. A., Price R. W. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol. 1986 Nov;45(6):635–646. doi: 10.1097/00005072-198611000-00003. [DOI] [PubMed] [Google Scholar]
  39. Power C., McArthur J. C., Johnson R. T., Griffin D. E., Glass J. D., Perryman S., Chesebro B. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol. 1994 Jul;68(7):4643–4649. doi: 10.1128/jvi.68.7.4643-4649.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Price R. W., Brew B. J. The AIDS dementia complex. J Infect Dis. 1988 Nov;158(5):1079–1083. doi: 10.1093/infdis/158.5.1079. [DOI] [PubMed] [Google Scholar]
  41. Pulliam L., West D., Haigwood N., Swanson R. A. HIV-1 envelope gp120 alters astrocytes in human brain cultures. AIDS Res Hum Retroviruses. 1993 May;9(5):439–444. doi: 10.1089/aid.1993.9.439. [DOI] [PubMed] [Google Scholar]
  42. Ranki A., Nyberg M., Ovod V., Haltia M., Elovaara I., Raininko R., Haapasalo H., Krohn K. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS. 1995 Sep;9(9):1001–1008. doi: 10.1097/00002030-199509000-00004. [DOI] [PubMed] [Google Scholar]
  43. Rosenberg Z. F., Fauci A. S. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today. 1990 May;11(5):176–180. doi: 10.1016/0167-5699(90)90070-p. [DOI] [PubMed] [Google Scholar]
  44. Rostad S. W., Sumi S. M., Shaw C. M., Olson K., McDougall J. K. Human immunodeficiency virus (HIV) infection in brains with AIDS-related leukoencephalopathy. AIDS Res Hum Retroviruses. 1987;3(4):363–373. doi: 10.1089/aid.1987.3.363. [DOI] [PubMed] [Google Scholar]
  45. Royal W., 3rd, Selnes O. A., Concha M., Nance-Sproson T. E., McArthur J. C. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia. Ann Neurol. 1994 Jul;36(1):32–39. doi: 10.1002/ana.410360109. [DOI] [PubMed] [Google Scholar]
  46. Sabatier J. M., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., Hue B., Bahraoui E. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol. 1991 Feb;65(2):961–967. doi: 10.1128/jvi.65.2.961-967.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Schmidtmayerova H., Nottet H. S., Nuovo G., Raabe T., Flanagan C. R., Dubrovsky L., Gendelman H. E., Cerami A., Bukrinsky M., Sherry B. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):700–704. doi: 10.1073/pnas.93.2.700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sei S., Saito K., Stewart S. K., Crowley J. S., Brouwers P., Kleiner D. E., Katz D. A., Pizzo P. A., Heyes M. P. Increased human immunodeficiency virus (HIV) type 1 DNA content and quinolinic acid concentration in brain tissues from patients with HIV encephalopathy. J Infect Dis. 1995 Sep;172(3):638–647. doi: 10.1093/infdis/172.3.638. [DOI] [PubMed] [Google Scholar]
  49. Shaw G. M., Harper M. E., Hahn B. H., Epstein L. G., Gajdusek D. C., Price R. W., Navia B. A., Petito C. K., O'Hara C. J., Groopman J. E. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science. 1985 Jan 11;227(4683):177–182. doi: 10.1126/science.2981429. [DOI] [PubMed] [Google Scholar]
  50. Shrikant P., Benos D. J., Tang L. P., Benveniste E. N. HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J Immunol. 1996 Feb 1;156(3):1307–1314. [PubMed] [Google Scholar]
  51. Spehar T., Strand M. Cross-reactivity of anti-human immunodeficiency virus type 1 gp41 antibodies with human astrocytes and astrocytoma cell lines. J Virol. 1994 Oct;68(10):6262–6269. doi: 10.1128/jvi.68.10.6262-6269.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Stoler M. H., Eskin T. A., Benn S., Angerer R. C., Angerer L. M. Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis. JAMA. 1986 Nov 7;256(17):2360–2364. [PubMed] [Google Scholar]
  53. Sundar K. S., Kamaraju L. S., Dingfelder J., McMahon J., Gollapudi S., Wilson W. H., Kong L. Y., Hong J. S., Weiss J. M., Lee J. E. beta-Endorphin enhances the replication of neurotropic human immunodeficiency virus in fetal perivascular microglia. J Neuroimmunol. 1995 Aug;61(1):97–104. doi: 10.1016/0165-5728(95)00089-k. [DOI] [PubMed] [Google Scholar]
  54. Talley A. K., Dewhurst S., Perry S. W., Dollard S. C., Gummuluru S., Fine S. M., New D., Epstein L. G., Gendelman H. E., Gelbard H. A. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol Cell Biol. 1995 May;15(5):2359–2366. doi: 10.1128/mcb.15.5.2359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Toggas S. M., Masliah E., Rockenstein E. M., Rall G. F., Abraham C. R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 1994 Jan 13;367(6459):188–193. doi: 10.1038/367188a0. [DOI] [PubMed] [Google Scholar]
  56. Vazeux R., Brousse N., Jarry A., Henin D., Marche C., Vedrenne C., Mikol J., Wolff M., Michon C., Rozenbaum W. AIDS subacute encephalitis. Identification of HIV-infected cells. Am J Pathol. 1987 Mar;126(3):403–410. [PMC free article] [PubMed] [Google Scholar]
  57. Volterra A., Trotti D., Cassutti P., Tromba C., Salvaggio A., Melcangi R. C., Racagni G. High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J Neurochem. 1992 Aug;59(2):600–606. doi: 10.1111/j.1471-4159.1992.tb09411.x. [DOI] [PubMed] [Google Scholar]
  58. Wigdahl B., Kunsch C. Role of HIV in human nervous system dysfunction. AIDS Res Hum Retroviruses. 1989 Aug;5(4):369–374. doi: 10.1089/aid.1989.5.369. [DOI] [PubMed] [Google Scholar]
  59. Wiley C. A., Nelson J. A. Human immunodeficiency virus: infection of the nervous system. Curr Top Microbiol Immunol. 1990;160:157–172. doi: 10.1007/978-3-642-75267-4_10. [DOI] [PubMed] [Google Scholar]
  60. Wiley C. A., Schrier R. D., Nelson J. A., Lampert P. W., Oldstone M. B. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7089–7093. doi: 10.1073/pnas.83.18.7089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Wilt S. G., Milward E., Zhou J. M., Nagasato K., Patton H., Rusten R., Griffin D. E., O'Connor M., Dubois-Dalcq M. In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy. Ann Neurol. 1995 Mar;37(3):381–394. doi: 10.1002/ana.410370315. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES